Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 976 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Endothelial Clear all

Conditions: Coronary Artery Disease
Interventions: FMD Arm; Dietary Supplement
Lead sponsor: Hypertension Institute, Nashville; Other
Eligibility: 35 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Secondary Pulmonary Arterial Hypertension
Interventions: Heart Catheterization; Procedure
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Fuchs' Endothelial Dystrophy, Bullous Keratopathy
Interventions: Netarsudil, Placebo; Drug
Lead sponsor: Cornea Research Foundation of America; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cardiovascular Diseases, Vascular Stiffness, Endothelial Dysfunction
Interventions: Not listed
Lead sponsor: Zhili hao; Other
Eligibility: 45 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Pain
Interventions: Intravitreal injection site; Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Aging, Menopause
Interventions: MitoQ, Placebo, Aerobic exercise; Dietary Supplement · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 120 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypercholesterolemia
Interventions: Diet: soybeans and products made thereof, Diet: soybean flour and products made thereof, Diet: soybean milk, Diet: Animal protein based diet; Other
Lead sponsor: Tufts University; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Metabolic Syndrome X
Interventions: Soy nuts, Matched food; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Davis, California

Conditions: Hyperparathyroidism, Secondary, Kidney Failure, Chronic
Interventions: doxercalciferol; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Artery Disease, Endothelial Dysfunction
Interventions: Music therapy; Other
Lead sponsor: Emmanouil Brilakis; Federal
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Aging
Interventions: Ankle splinting; Other
Lead sponsor: University of Florida; Other
Eligibility: 60 Years to 79 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: HIV Infection
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Prediabetes, Cardiovascular Disease
Interventions: Glucose (100g), Glucose (75g), Whole Eggs, Egg Whites, Egg Yolks; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2020
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Depression, HIV
Interventions: Beating the Blues; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Coronary Arteriosclerosis
Interventions: Forearm blood flow study, Brachial artery reactivity study, Treadmill exercise test; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 22 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Menstrual Bleeding, Heavy
Interventions: Sample Collection and Endometrial Biopsy; Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Type II Diabetes Mellitus
Interventions: Spice polyphenols; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 35 Years to 70 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Corneal Endothelial Cell Loss
Interventions: Topcon Specular Microscope SP-1P, Konan Specular Microscope CELLCHEK XL; Device
Lead sponsor: Topcon Medical Systems, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Lymphedema
Interventions: Pazopanib; Drug
Lead sponsor: Kathy Miller; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Peripheral Vascular Diseases
Interventions: G-CSF, Placebo, Aspirin, Clopidogrel; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Malignant Ascites
Interventions: Bevacizumab; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 3
States / cities: Houston, Texas

Conditions: HIV Infections
Interventions: LDMTX, Placebo, Folic acid; Drug · Dietary Supplement
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 40 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 22
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 18 more

Conditions: Hypertension in Pregnancy
Interventions: Docosahexaenoic acid 200 mg, Docosahexaenoic acid 1000 mg; Dietary Supplement · Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Evaluation of a Fasting Mimicking Diet

Endothelial Cell Dysfunction in Pulmonary Hypertension

Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation

Microfluidic-based Tactile Sensor in Cardiac Rehabilitation

Intravitreal Injection Site and Perceived Pain

MitoQ and Exercise Effects on Vascular Health

Soybean Based Diets and CVD Risk Factors

Soy Nut Study on Markers of Health

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy

Effect of Ankle Splinting on Vascular Function in Aging

Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People

Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults

Study of Venous Endothelial Cells in Rheumatoid Arthritis

Depression Therapy to Improve Cardiovascular Risk in HIV

Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease

PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes

Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements

A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease

A Study of Bevacizumab to Prevent Malignant Ascites

Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications

Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health